HB-EGF orchestrates the complex signals involved in triple-negative and trastuzumab-resistant breast cancer-Reference-Cited by-同舟云学术

HB-EGF orchestrates the complex signals involved in triple-negative and trastuzumab-resistant breast cancer

Published:2010-07-27 Issue:11 Volume:127 Page:2707-2717
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Yotsumoto Fusanori,Oki Eiji,Tokunaga Eriko,Maehara Yoshihiko,Kuroki Masahide,Miyamoto Shingo

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference45 articles.

1. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

2. P27kip1 down-regulation is associated with trastuzumab resistance in breast cancer cells;Nahta;Cancer Res,2004

3. PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients;Nagata;Cancer Cell,2004

4. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation;Diermeier;Exp Cell Res,2005

5. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides;Motoyama;Cancer Res,2002

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomimetic MicroRNAs‐Selenium‐Nanocomposites for Targeted and Combined Hyperlipidemia Therapy;Advanced Healthcare Materials;2024-03-15

2. The Multiple Functions of HB-EGF in Female Reproduction and Related Cancer: Molecular Mechanisms and Targeting Strategies;Reproductive Sciences;2024-02-29

3. Nano-scale delivery systems for siRNA delivery in cancer therapy: New era of gene therapy empowered by nanotechnology;Environmental Research;2023-12

4. Advances with Lipid-Based Nanosystems for siRNA Delivery to Breast Cancers;Pharmaceuticals;2023-07-06

5. Targeting the TR4-induced RCC cells-derived exosomally initiated signaling increases Sunitinib efficacy;2022-12-11